ARC Group, a leading global investment bank specializing in cross-border transactions and capital markets advisory, is pleased to announce that it acted as the exclusive financial advisor on the merger transaction between Titan Pharmaceuticals, Inc. (“Titan” or “TTNP”) and TalenTec Sdn. Bhd. (“TalenTec”), resulting in Black Titan Corporation (“Black Titan” or “BTTC”) as the parent company and reporting issuer. 

Under the terms of the Merger and Contribution and Share Exchange Agreement dated August 19, 2024, Titan has become a wholly owned subsidiary of Black Titan Corporation, effective as of October 1, 2025. Following the merger, the combined company’s ordinary shares trade on the Nasdaq Stock Exchange under the ticker symbol NASDAQ: BTTC. 

As part of the transaction, each issued and outstanding share of Titan common stock was automatically converted into ordinary shares of Black Titan on a one-for-one basis. Trading of Titan’s common stock on the Nasdaq Capital Market ceased at the close of business on October 1, 2025, and Black Titan’s ordinary shares commenced trading on Nasdaq on October 2, 2025. 

Since the merger and Nasdaq listing, BTTC has shown a strong upward revaluation, with shares trading significantly higher than pre-merger levels, reflecting robust investor interest in the newly combined entity. 

Nigel Wong, Director at ARC Group, commented:

“We are proud to have supported Black Titan through this transformative merger, which underscores ARC Group’s continued commitment to helping visionary companies access global capital markets. This transaction not only strengthens Black Titan’s strategic position but also reflects the growing cross-border collaboration shaping the future of the life sciences industry.”

Chay W. J., CEO of Black Titan, remarked, “This merger represents more than a structural change, it’s the beginning of a new chapter of innovation and global expansion. We are well-positioned to execute our strategic vision and bring transformative value to our stakeholders.”

This transaction further highlights ARC Group’s strong track record in advising cross-border mergers and acquisitions, particularly in complex, multi-jurisdictional structures involving U.S. public markets.

About ARC Group

ARC Group is a globally based investment bank and management consultancy firm, specializing in bridging Asia and the West. Our services encompass a full spectrum of financial solutions, including IPOs, M&A, financing, venture capital, and SPACs. ARC Group also includes an independent consulting division dedicated to addressing the unique challenges faced by companies operating across both Asian and Western markets. Headquartered in Hong Kong, with offices across Mainland China, the USA, Malaysia, Indonesia, Vietnam, India, Sweden, and the UAE, we are well-positioned to provide cross-border financial and advisory services.

Our commitment to anticipating market trends and delivering client-centered solutions has earned ARC Group the Frost & Sullivan 2024 Company of the Year Award in the Asian mid-market investment advisory sector.

For more information or any questions, please contact:

Nigel Wong
Director
[email protected]

For media inquiries, please contact:

Anna Sahlberg Carlsson
Marketing Manager
[email protected]